Close Menu
    mogadishulive.commogadishulive.com
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    mogadishulive.commogadishulive.com
    Home » Maypharm Launches METOO FILL HA FILLER, Metox botulinum toxin with a 2nd generation technological advantage
    PR Newswire

    Maypharm Launches METOO FILL HA FILLER, Metox botulinum toxin with a 2nd generation technological advantage

    August 15, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    SEOUL, South Korea and NEW YORK, Aug. 15, 2023 /PRNewswire/ — Maypharm CO, LTD, known as a Korean manufacturer, recently successfully launched Metox botulinum toxin with a 2nd generation technological advantage and meNnus PLA filler for collagen regeneration using only advanced technologies in the developed products that are responsible for their safety and effectiveness.

    METOO FILL HA FILLER

    For many years, France, Germany, and USA have been considered constant leaders in the field of cosmetology and innovations in the creation of products for cosmetology market. But everything changed after the entry into the arena of South Korea, a country that has made a real revolution in the beauty industry, incorporating the use of innovative technologies into production, and introducing products to the world that has no analogues before.

    METOOFILL hyaluronic acid dermal filler (CE Approved), made by Maypharm CO, LTD, overcame the limitations of traditional hyaluronic acid cross-linking technology by using patented innovative three patented technologies.

    1. Microbead Monophasic Technology

    This patented technology increases the gel’s durability with a homogeneous structure of HA particles that provides stable volume, outstanding cohesion, and migration resistance.

    2. Multi-stage Cross-linking Technology

    Metoo Fill goes through a three-stage high-rate DVS cross linking process that optimizes density, provides outstanding viscoelastic properties, flexibility and an improved injectability profile while retaining the biocompatibility and physical functionality of unmodified HA.

    3. Multi-degree Amphiphilic Purification

    After cross-linking, Metoo Fill goes through a multi-step purification process to completely neutralize the cross-linking agent using PBS solution, resulting in a network of HA chains with a purity of over 97%, as opposed to other products in the market with a purity up to 95%.

    As a result, the Metoo Fill series contains 4 lines with different gel parameters for various needs: Applying these three patented technologies, the products METOO FILL are longer-lasting, easily moldable, resulting in a very natural finish that will satisfy the client.

    For further details, please contact us at maypharm@maypharm.co.kr or visit our website, https://www.may-pharm.com/

    METOO FILL HA FILLER

    Photo – https://mma.prnewswire.com/media/2185792/METOO_FILL_HA_FILLER.jpg
    Photo – https://mma.prnewswire.com/media/2185793/METOO_FILL_HA_FILLER2.jpg

    Cision View original content:https://www.prnewswire.co.uk/news-releases/maypharm-launches-metoo-fill-ha-filler-metox-botulinum-toxin-with-a-2nd-generation-technological-advantage-301900737.html

    Related Posts

    Next Level Aviation® Appoints Mike Fleener as Senior Vice President of Global Sales

    August 19, 2026

    XCMG Accelerates Global Equipment Deliveries for Infrastructure and Mining Projects

    August 17, 2026

    Skye Africa Intelligence and ECSA-HC Sign Memorandum of Understanding to Scale AI-Enabled Health Solutions

    August 5, 2026

    Boao Forum: CRRC Zhuzhou Institute Outlines Core Technologies and Application-Driven Innovation for Green Industry Growth

    August 4, 2026

    Sungrow Powers Sierra Leone’s Energy Transformation with First National-Scale Power Project

    July 31, 2026

    Investec Selects Infosys Finacle SaaS Platform on Microsoft Azure for Digital Banking Transformation

    July 30, 2026
    Latest News

    Alibaba secures HK$80 billion to expand AI investment

    August 24, 2026

    Alibaba Group has priced an HK$80 billion share placement to fund artificial intelligence investment and expand its AI infrastructure. The Chinese technology group will issue 710 million new ordinary shares at HK$112.70 each. The deal is worth about US$10.2 billion at current exchange rates. Alibaba expects the transaction to close on Aug. 26, subject to customary conditions.

    South Korea launches Arctic container ship trial to Europe

    August 24, 2026

    Nearly 22,000 Pakistanis deported from Gulf over 4 months

    August 22, 2026

    Australian team finds new way to tackle triple-negative breast cancer

    August 22, 2026

    Japan posts record July trade as imports outpace exports

    August 21, 2026

    DR Congo allocated 70,000 doses for Ebola outbreak

    August 21, 2026

    Wall Street rises after Treasury expands debt buybacks

    August 20, 2026

    WHO maps three-month path for Congo Ebola containment

    August 19, 2026
    © 2026 Mogadishu Live | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.